ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

DEVELOPING BIOMARKERS IN MOOD DISORDERS RESEARCH THROUGH THE USE OF RAPID-ACTING ANTIDEPRESSANTS

Niciu, Mark J.; Mathews, Daniel C.; Nugent, Allison C.; Ionescu, Dawn F.; Furey, Maura L.; Richards, Erica M.; Machado-Vieira, Rodrigo; Zarate, Carlos A., Jr.*
Depression and Anxiety2014-4DOI: 10.1002/da.22224
34被引2阅读
引用收藏
分享

摘要

An impediment to progress in mood disorders research is the lack of analytically valid and qualified diagnostic and treatment biomarkers. Consistent with the National Institute of Mental Health (NIMH)'s Research Domain Criteria (RDoC) initiative, the lack of diagnostic biomarkers has precluded us from moving away from a purely subjective (symptom-based) toward a more objective diagnostic system. In addition, treatment response biomarkers in mood disorders would facilitate drug development and move beyond trial-and-error toward more personalized treatments. As such, biomarkers identified early in the pathophysiological process are proximal biomarkers (target engagement), while those occurring later in the disease process are distal (disease pathway components). One strategy to achieve this goal in biomarker development is to increase efforts at the initial phases of biomarker development (i.e. exploration and validation) at single sites with the capability of integrating multimodal approaches across a biological systems level. Subsequently, resultant putative biomarkers could then undergo characterization and surrogacy as these latter phases require multisite collaborative efforts. We have used multimodal approaches - genetics, proteomics/metabolomics, peripheral measures, multimodal neuroimaging, neuropsychopharmacological challenge paradigms and clinical predictors - to explore potential predictor and mediator/moderator biomarkers of the rapid-acting antidepressants ketamine and scopolamine. These exploratory biomarkers may then be used for a priori stratification in larger multisite controlled studies during the validation and characterization phases with the ultimate goal of surrogacy. In sum, the combination of target engagement and well-qualified disease-related measures are crucial to improve our pathophysiological understanding, personalize treatment selection, and expand our armamentarium of novel therapeutics.

学科与关键词

关键词
biomarkerpredictormediatormoderatordepressionmajor depressive disorderbipolar disorderbipolar depressiondrug developmentneuroimaging
相关
加载中…
  • Biomarkers in mood disorders research: developing new and improved therapeutics
    Niciu, Mark J.; Mathews, Daniel C.; Ionescu, Dawn F.; Richards, Erica M.; Furey, Maura L.; Yuan, Peixiong; Nugent, Allison C.; Henter, Ioline D.; Machado-Vieira, Rodrigo; Zarate, Carlos A., Jr.*ARCHIVES OF CLINICAL PSYCHIATRY, 2014, 41(5): 131-134.被引 9
  • Precision Psychiatry: Biomarker-Guided Tailored Therapy for Effective Treatment and Prevention in Major Depression
    Jones, Candace; Nemeroff, Charles B.*SPRINGER-VERLAG SINGAPORE PTE LTD,152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE, 2021.被引 7
  • Diagnostic and clinical implications of functional neuroimaging in bipolar disorder
    Brooks, John O., III*; Vizueta, NathalieJournal of Psychiatric Research, 2014, 57: 12-25.被引 31
查看全部 →

发表信息

论文状态
公开发表
期刊
Depression and Anxiety
发表日期
2014-04
卷期
第 31 卷, 第 4 期
页码
297-307
DOI
10.1002/da.22224
语言
ENGLISH
期刊收录
SSCI.SCIE
期刊等级
Q1
成果收录
SCIE
资助标注
NARSAD; Brain & Behavior Research Foundation Mood Disorders Research Award

作者

  • N

    Niciu, Mark J. (第一作者)

  • M

    Mathews, Daniel C.

查看全部 8 位作者收起作者
  • N

    Nugent, Allison C.

  • I

    Ionescu, Dawn F.

  • F

    Furey, Maura L.

  • R

    Richards, Erica M.

  • M

    Machado-Vieira, Rodrigo

  • Z

    Zarate, Carlos A., Jr. (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417